See more : Koninklijke Ahold Delhaize N.V. (AHODF) Income Statement Analysis – Financial Results
Complete financial analysis of Medivolve Inc. (MEDVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medivolve Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Kunlun Energy Company Limited (0135.HK) Income Statement Analysis – Financial Results
- BASF SE (BFFAF) Income Statement Analysis – Financial Results
- Sam Woo Construction Group Limited (3822.HK) Income Statement Analysis – Financial Results
- Arcadis NV (ARCAY) Income Statement Analysis – Financial Results
- Chunghwa Telecom Co., Ltd. (2412.TW) Income Statement Analysis – Financial Results
Medivolve Inc. (MEDVF)
About Medivolve Inc.
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 686.45K | 37.18M | 86.82M | 1.48M | -152.11K | 17.64K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.18K | 0.00 |
| Cost of Revenue | 111.10K | 22.79M | 50.26M | 5.98M | 1.05M | 0.00 | 2.24K | 204.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 575.35K | 14.39M | 36.57M | -4.50M | -1.20M | 17.64K | -2.24K | -204.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.78K | 0.00 | 0.00 | 0.00 | 6.18K | 0.00 |
| Gross Profit Ratio | 83.82% | 38.70% | 42.12% | -305.00% | 787.59% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
| Research & Development | 380.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.40M | 26.20M | 18.36M | 8.41M | 2.27M | 878.31K | 3.28M | 939.95K | 956.07K | 1.61M | 1.62M | 1.64M | 1.97M | 2.05M | 1.81M | 1.19M | 142.49K | 0.00 |
| Selling & Marketing | 193.55K | 187.58K | 3.28M | 1.45M | 22.70K | 0.00 | 0.00 | 853.00 | 6.07K | 63.70K | 83.81K | 42.61K | 47.37K | 71.51K | 0.00 | 81.53K | 2.39K | 0.00 |
| SG&A | 3.59M | 26.38M | 21.64M | 9.86M | 2.27M | 878.31K | 3.28M | 940.81K | 962.13K | 1.67M | 1.71M | 1.68M | 2.02M | 2.05M | 1.81M | 1.27M | 144.87K | 134.48K |
| Other Expenses | 564.49K | 0.00 | -1.29M | 0.00 | -1.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.16M | 26.90M | 22.86M | 13.16M | 2.42M | 1.01M | 4.00M | 1.06M | 989.23K | 1.94M | 1.74M | 1.70M | 2.08M | 2.08M | 1.81M | 1.27M | 144.87K | 134.48K |
| Cost & Expenses | 4.27M | 49.69M | 73.11M | 19.13M | 2.42M | 1.01M | 4.00M | 1.06M | 989.23K | 1.94M | 1.74M | 1.70M | 2.08M | 2.08M | 1.81M | 1.27M | 144.87K | 134.48K |
| Interest Income | 0.00 | 287.00 | 57.97K | 62.12K | 52.74K | 17.64K | 4.26K | 0.00 | 1.16K | 3.53K | 22.04K | 39.94K | 52.70K | 35.02K | 25.47K | 7.84K | 6.18K | 0.00 |
| Interest Expense | 0.00 | 238.03K | 482.70K | 86.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 110.00 | 0.00 | 0.00 | 1.44K | 683.00 | 78.00 |
| Depreciation & Amortization | 400.23K | 1.55M | 4.82M | 3.17M | 2.36M | 1.62K | 2.24K | 204.00 | 146.98K | 100.23K | 36.81K | 15.63K | 1.61K | 494.00 | 19.29K | 1.44K | 0.00 | 0.00 |
| EBITDA | -2.97M | -11.57M | 18.53M | -19.02M | -2.38M | -920.85K | -3.93M | -819.52K | -842.03K | -1.84M | -1.86M | -1.58M | -2.08M | -2.03M | -1.79M | -1.27M | -138.70K | -134.48K |
| EBITDA Ratio | -433.08% | -2.49% | 19.57% | -1,288.76% | 1,565.98% | -7,294.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,246.14% | 0.00% |
| Operating Income | -3.58M | -22.79M | 1.18M | -22.19M | -2.38M | -1.29M | -4.06M | -867.81K | -989.01K | -1.94M | -1.67M | -1.71M | -2.08M | -2.08M | -1.81M | -1.27M | -138.70K | -134.48K |
| Operating Income Ratio | -521.53% | -61.31% | 1.36% | -1,503.90% | 1,565.98% | -7,294.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,246.14% | 0.00% |
| Total Other Income/Expenses | -332.62K | -8.39M | -25.80K | -13.35M | -141.78K | 210.90K | 7.10M | 58.14K | -212.73K | -96.87K | 16.72K | 36.43K | 240.09K | 0.00 | -19.29K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -3.91M | -22.88M | -154.04K | -37.78M | -2.72M | -711.56K | 3.17M | -761.31K | -1.13M | -2.04M | -1.84M | -3.30M | -1.84M | 0.00 | -1.83M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -569.98% | -61.54% | -0.18% | -2,559.89% | 1,787.07% | -4,033.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -4.51M | 6.46M | 86.95K | -2.22M | -298.15K | -7.16M | -295.47K | -1.39K | -3.45K | 4.15M | 1.60M | -240.09K | -35.02K | -25.47K | -7.84K | 139.38K | 134.56K |
| Net Income | -16.46M | -18.37M | -6.61M | -37.78M | -2.72M | -711.56K | 3.17M | -761.31K | -1.13M | -2.04M | -5.89M | -3.30M | -1.84M | -2.04M | -1.81M | -1.27M | -139.38K | -134.56K |
| Net Income Ratio | -2,397.53% | -49.40% | -7.61% | -2,559.89% | 1,787.07% | -4,033.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,257.20% | 0.00% |
| EPS | -0.14 | -0.68 | -0.34 | -5.66 | -1.19 | -0.31 | 1.35 | -0.59 | -2.48 | -4.54 | -13.28 | -7.48 | -4.88 | -7.36 | -9.16 | -13.01 | -1.90 | -1.65 |
| EPS Diluted | -0.61 | -0.68 | -0.34 | -5.66 | -1.19 | -0.31 | 1.35 | -0.59 | -2.48 | -4.54 | -13.28 | -7.48 | -4.88 | -7.36 | -9.16 | -13.01 | -1.90 | -1.65 |
| Weighted Avg Shares Out | 120.08M | 27.02M | 19.32M | 6.67M | 2.28M | 2.28M | 2.28M | 1.29M | 456.89K | 449.48K | 443.56K | 441.33K | 377.53K | 277.92K | 197.21K | 97.31K | 73.35K | 81.67K |
| Weighted Avg Shares Out (Dil) | 27.02M | 27.02M | 19.32M | 6.67M | 2.28M | 2.28M | 2.28M | 1.29M | 456.89K | 449.48K | 443.56K | 441.33K | 377.53K | 277.92K | 197.21K | 97.31K | 73.35K | 81.67K |
Medivolve Announces Management Changes
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024....
Medivolve Announces Change of Auditor
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP...
Medivolve announces telehealth platform development contract; management and director changes
Medivolve Inc. (NEO:MEDV.AQN, OTC:COPRF) told investors it entered into a master service agreement with Engineer.ai Corp doing business as Builder.ai to assist in the development of its telehealth platform. Under the December 29, 2023 agreement, the company said features that Builder will...
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is pleased to announce that it has entered into a master services agreement dated December 29, 2023, with Engineer.ai Corp. (dba Builder.ai)...
Medivolve Announces Change of Auditor and Board Changes
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from McGovern Hurley LLP (“McGovern”) to MNP LLP (“MNP”), effective November 9, 2023. At the request...
Medivolve Announces Board Changes
TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces today that Dr. Beverley Richardson has resigned from its board of directors, effective immediately. The Company intends to announce the appointment...
Medivolve establishes a management services organization in Puerto Rico
Medivolve Inc. (NEO:MEDV.AQN, OTC:COPRF) has announced the establishment of Medivolve Management Services LLC in Puerto Rico, which will serve as a management services organization (MSO), adhering to the applicable regulations governing medical practice in the US. Through the MSO, Medivolve said it aims...
Medivolve closes previously announced secured convertible note financing for aggregate gross proceeds of $1.2M
Medivolve Inc. (NEO:MEDV.AQN, OTC:COPRF) said it has closed its previously announced secured convertible note financing for aggregate gross proceeds to the company of $1.2 million, which included a $200,000 original issue discount. The company said it plans to use the...
Source: https://incomestatements.info
Category: Stock Reports